Bio-Rad announced the launch of qUAntify Advance Control for use in clinical labs performing urinalysis testing.
Bio-Rad announced expanded global access of the company’s quality controls across multiple Abbott clinical diagnostics platforms that now includes the Abbott Alinity ci-series instruments.
Inpeco and Bio-Rad announced their partnership to connect the Inpeco FlexLab track and the D-100 System to provide high-volume laboratories improved operational efficiencies to meet the growing worldwide demand for diabetes testing.
Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding its Critical Raw Materials Portfolio
Bio-Rad Receives FDA Clearance to Aid in Diagnosing Diabetes with its D-10 Hemoglobin A1c Program
Bio-Rad Signs Agreement with VISIA Imaging for Fully-Automated IFA Slide Processing and Reading System
Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control
The BioPlex 2200 ToRC IgM Assay is a fully automated assay for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus (CMV) offered in a multiplexed panel.
Microsoft operating systems recently experienced a security vulnerability resulting from a widespread ransomware attack through Microsoft’s network environments on a global scale. Bio-Rad’s internal IT team has evaluated the technical details of the Microsoft security update and has approved the patch.
Bio-Rad Launches Amplichek STI, the Third in a Series of Quality Controls for the Molecular Diagnostics Testing Market